The US Food and Drug Administration on Friday said it warned that Genentech Inc's key cancer drug Avastin can cause an increased risk of deadly blood clots in arteries.
The company, which makes the drug with its Swiss-based majority owner Roche Holding AG, sent a letter to health care providers about the serious risk.